$33.32
+0.460 (+1.40%)
At Close: Jun 03, 2026
Earnings Outlook for Harrow Health
10:21am, Friday, 06'th Nov 2020
Harrow Health (NASDAQ: HROW) will be releasing its next round of earnings this Monday, November 09. For all of the relevant information, here is your guide for Monday's Q3 earnings announcement.
Harrow Health to Announce Third Quarter 2020 Financial Results on November 9, 2020
07:30am, Tuesday, 27'th Oct 2020
NASHVILLE, Tenn., Oct. 27, 2020 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced that after the close of trading on Monday, November 9, 2020, it will release third quarter 2020 f
Our Take On Eton Pharmaceuticals
03:23pm, Tuesday, 01'st Sep 2020
Shares of 505(b)(2) concern Eton Pharmaceuticals, Inc. have more than doubled off their mid-March lows and are now above where they started the year.
Harrow Health Is On The Mend
06:19pm, Tuesday, 25'th Aug 2020
The strong momentum developed by Harrow Health was temporarily short-circuited by the COVID-19 crisis.
Harrow Health (HROW) Reports Q2 Loss, Tops Revenue Estimates
12:05am, Tuesday, 11'th Aug 2020
Harrow (HROW) delivered earnings and revenue surprises of 80.00% and 36.61%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Harrow Health Publishes Second Quarter 2020 Letter to Stockholders
08:00pm, Monday, 10'th Aug 2020
NASHVILLE, Tenn., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today reported results for the second quarter 2020. Please click here to review Harrow Health’s Letter to Sto
Harrow Health's Earnings Outlook
03:05pm, Friday, 07'th Aug 2020
On Monday, August 10, Harrow Health (NASDAQ: HROW) will release its latest earnings report. Benzinga's outlook for Harrow Health is included in the following report.Earnings and Revenue Based on manag
EyePoint Pharmaceuticals and Harrow Health’s ImprimisRx Announce U.S. Commercial Alliance for DEXYCU®
11:00am, Tuesday, 04'th Aug 2020
\- Collaboration to bring DEXYCU to ImprimisRx’s established customer base of ophthalmologists, hospitals, and ambulatory surgical centers -WATERTOWN, Mass. and NASHVILLE, Tenn., Aug. 04, 2020 (GLOB
Analysts Estimate Harrow Health (HROW) to Report a Decline in Earnings: What to Look Out for
04:31pm, Monday, 03'rd Aug 2020
Harrow (HROW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Harrow Health to Announce Second Quarter 2020 Financial Results on August 10, 2020
11:30am, Monday, 27'th Jul 2020
NASHVILLE, Tenn., July 27, 2020 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced that after the close of trading on Monday, August 10, 2020, it will release second quarter 2020 f
If You Had Bought Harrow Health (NASDAQ:HROW) Shares Three Years Ago You'd Have Earned119% Returns
02:24pm, Friday, 24'th Jul 2020
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But if you buy shares in a...
5,000 Shares in Harrow Health (NASDAQ:HROW) Purchased by Whittier Trust Co.
08:35pm, Thursday, 16'th Jul 2020
Whittier Trust Co. acquired a new position in Harrow Health (NASDAQ:HROW) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The insti
Leading Peer-Reviewed Journal Publishes Clinical Study on ImprimisRx’s Combination Prescription Eyedrops
11:30am, Monday, 13'th Jul 2020
SAN DIEGO, July 13, 2020 -- ImprimisRx, the nation’s leading ophthalmic-focused outsourcing facility and pharmaceutical compounding business, a wholly-owned subsidiary.
The London boroughs that look most at risk of going back into lockdown
10:17pm, Tuesday, 30'th Jun 2020
There have been new cases in every borough over the last two weeks
Were Hedge Funds Right About Harrow Health, Inc. (HROW)?
02:12pm, Tuesday, 30'th Jun 2020
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). In these volatile market
Sign In
Buy HROW